Kate D. Meyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kate D. Meyer has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Samie R. Jaffrey
Department of Pharmacology, Weill Medical College, Cornell University
8 shared publications Matthew Tegowski
Department of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA
6 shared publications- Mathieu N. Flamand
Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina 27710, USA
4 shared publications - Christopher E. Mason
Department of Physiology and Biophysics, Weill Cornell Medicine, New York, USA
3 shared publications Huanyu Zhu
Department of Biochemistry, Duke University School of Medicine, Durham NC 27710, USA
3 shared publicationsMathieu N. Flamand
Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, USA
3 shared publications
Latest Publications
- 22 June 2026
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 27 (8) , 571-590
m6A in RNA: a key regulator of brain development, function and disease
Epitranscriptomic regulation of cellular RNAs is a major mechanism of gene expression control in the brain. N6-Methyladenosine (m6A) is installed on thousands of mRNAs and non-coding RNAs, where it functions as a context-dependent regulator of RNA-protein interactions to control the amplitude and kinetics of gene expression. In the nervous system, m6A is critical for neurodevelopment, synaptic plasticity and adaptive responses to physiological stimuli, and its dysregulation has been linked to various brain disorders. In this Review, we present a comprehensive synthesis of how m6A is deposited, interpreted and dynamically regulated, and integrate recent advances to present a unified framework for its function in neural cells. We discuss how m6A coordinates RNA stability, translation, localization and chromatin-associated processes across developmental and adult contexts and how disruption of these pathways contributes to neurological disease. Finally, we explore challenges and future directions for the field.
- 22 June 2026
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 27 (8) , 571-590
m6A in RNA: a key regulator of brain development, function and disease
Epitranscriptomic regulation of cellular RNAs is a major mechanism of gene expression control in the brain. N6-Methyladenosine (m6A) is installed on thousands of mRNAs and non-coding RNAs, where it functions as a context-dependent regulator of RNA-protein interactions to control the amplitude and kinetics of gene expression. In the nervous system, m6A is critical for neurodevelopment, synaptic plasticity and adaptive responses to physiological stimuli, and its dysregulation has been linked to various brain disorders. In this Review, we present a comprehensive synthesis of how m6A is deposited, interpreted and dynamically regulated, and integrate recent advances to present a unified framework for its function in neural cells. We discuss how m6A coordinates RNA stability, translation, localization and chromatin-associated processes across developmental and adult contexts and how disruption of these pathways contributes to neurological disease. Finally, we explore challenges and future directions for the field.
- Open Access
Transcript architecture sets the m 6 A landscape: CSTF2 and CSTF2T reshape m 6 A through cleavage-dependent and -independent mechanisms
Summary: Alternative RNA processing generates extensive transcript diversity, yet how transcript architecture influences selective m 6 A deposition is incompletely understood. Exon-junction-based models explain where m 6 A is excluded, but a positive determinant of m 6 A accumulation remains undefined. Here, we leverage Zika virus-induced changes in m 6 A deposition to uncover determinants of transcript-selective methylation. By integrating GLORI-seq, native METTL3 RNA immunoprecipitation, and nanopore direct RNA sequencing, we generate a single-nucleotide, isoform-resolved map of m 6 A dynamics during infection. We identify over 2,000 dynamic m 6 A sites, many arising from changes in transcript architecture, and pinpoint proximal polyadenylation sites as positive determinants of m 6 A accumulation. The cleavage stimulation factors CSTF2 and CSTF2T drive this remodeling through two routes: redundant induction of intronic polyadenylation, which converts internal exons into terminal exons that expose DRACH motifs to METTL3, and non-redundant, cleavage-independent recruitment of METTL3 near proximal polyadenylation sites, establishing alternative polyadenylation as a key architectural determinant of the m 6 A landscape.
Open AccessTranscript architecture sets the m 6 A landscape: CSTF2 and CSTF2T reshape m 6 A through cleavage-dependent and -independent mechanisms
Summary: Alternative RNA processing generates extensive transcript diversity, yet how transcript architecture influences selective m 6 A deposition is incompletely understood. Exon-junction-based models explain where m 6 A is excluded, but a positive determinant of m 6 A accumulation remains undefined. Here, we leverage Zika virus-induced changes in m 6 A deposition to uncover determinants of transcript-selective methylation. By integrating GLORI-seq, native METTL3 RNA immunoprecipitation, and nanopore direct RNA sequencing, we generate a single-nucleotide, isoform-resolved map of m 6 A dynamics during infection. We identify over 2,000 dynamic m 6 A sites, many arising from changes in transcript architecture, and pinpoint proximal polyadenylation sites as positive determinants of m 6 A accumulation. The cleavage stimulation factors CSTF2 and CSTF2T drive this remodeling through two routes: redundant induction of intronic polyadenylation, which converts internal exons into terminal exons that expose DRACH motifs to METTL3, and non-redundant, cleavage-independent recruitment of METTL3 near proximal polyadenylation sites, establishing alternative polyadenylation as a key architectural determinant of the m 6 A landscape.
- Open Access
Loss of age-associated increase in m 6 A-modified RNA contributes to GABAergic dysregulation in Alzheimer’s disease
Dysregulated RNA metabolism is a significant feature of Alzheimer’s disease (AD), yet how post-transcriptional RNA modifications like N 6 -methyladenosine (m 6 A) are altered in AD is unknown. Here, we performed d eamination a djacent to R NA modification targets (DART-seq) on human dorsolateral prefrontal cortices to assess changes in m 6 A with nucleotide resolution. In non-AD brains, m 6 A sites increased with age, predominantly within the 3′UTR of transcripts encoding tripartite synapse proteins. In contrast, AD brains lost the age-associated m 6 A site increase and exhibited global hypomethylation of transcripts, including MAPT and APP . Hypomethylated genes involved with GABAergic signaling, glutamate transport, and ubiquitin-mediated proteolysis exhibited reduced expression, connecting m 6 A to synaptic excitotoxicity and disrupted proteostasis in AD. Site-specific m 6 A levels were linked with GABRA1 expression and protein levels, but this relationship was abolished in AD. Our findings provide insight into post-transcriptional mechanisms of dysregulated RNA metabolism in AD that are related to aging and GABAergic regulation. HIGHLIGHTS: With age, the number of m 6 A sites increases among Control cases (lacking AD pathology) but remains unchanged in AD cases. Transcripts are globally hypomethylated in AD cases. Hypomethylation is linked to decreased mRNA expression of transcripts related to synaptic and proteostatic function in AD. 3’UTR-localized m 6 A sites lack typical association with transcript metabolism of GABRA1 in AD. Graphical
Open AccessLoss of age-associated increase in m 6 A-modified RNA contributes to GABAergic dysregulation in Alzheimer’s disease
Dysregulated RNA metabolism is a significant feature of Alzheimer’s disease (AD), yet how post-transcriptional RNA modifications like N 6 -methyladenosine (m 6 A) are altered in AD is unknown. Here, we performed d eamination a djacent to R NA modification targets (DART-seq) on human dorsolateral prefrontal cortices to assess changes in m 6 A with nucleotide resolution. In non-AD brains, m 6 A sites increased with age, predominantly within the 3′UTR of transcripts encoding tripartite synapse proteins. In contrast, AD brains lost the age-associated m 6 A site increase and exhibited global hypomethylation of transcripts, including MAPT and APP . Hypomethylated genes involved with GABAergic signaling, glutamate transport, and ubiquitin-mediated proteolysis exhibited reduced expression, connecting m 6 A to synaptic excitotoxicity and disrupted proteostasis in AD. Site-specific m 6 A levels were linked with GABRA1 expression and protein levels, but this relationship was abolished in AD. Our findings provide insight into post-transcriptional mechanisms of dysregulated RNA metabolism in AD that are related to aging and GABAergic regulation. HIGHLIGHTS: With age, the number of m 6 A sites increases among Control cases (lacking AD pathology) but remains unchanged in AD cases. Transcripts are globally hypomethylated in AD cases. Hypomethylation is linked to decreased mRNA expression of transcripts related to synaptic and proteostatic function in AD. 3’UTR-localized m 6 A sites lack typical association with transcript metabolism of GABRA1 in AD. Graphical
- 24 September 2024
- Published by Springer Nature in Nature Neuroscience
- Vol. 27 (12) , 2512-2520
Single-cell m6A profiling in the mouse brain uncovers cell type-specific RNA methylomes and age-dependent differential methylation
N6-methyladenosine (m6A) is an abundant mRNA modification in the brain that has important roles in neurodevelopment and brain function. However, because of technical limitations, global profiling of m6A sites within the individual cell types that make up the brain has not been possible. Here, we develop a mouse model that enables transcriptome-wide m6A detection in any tissue of interest at single-cell resolution. We use these mice to map m6A across different brain regions and within single cells of the mouse cortex and discover a high degree of shared methylation across brain regions and cell types. However, we also identify a small number of differentially methylated mRNAs in neurons that encode important regulators of neuronal signaling, and we discover that microglia have lower levels of m6A than other cell types. Finally, we perform single-cell m6A mapping in aged mice and identify many transcripts with age-dependent changes in m6A.
- 24 September 2024
- Published by Springer Nature in Nature Neuroscience
- Vol. 27 (12) , 2512-2520
Single-cell m6A profiling in the mouse brain uncovers cell type-specific RNA methylomes and age-dependent differential methylation
N6-methyladenosine (m6A) is an abundant mRNA modification in the brain that has important roles in neurodevelopment and brain function. However, because of technical limitations, global profiling of m6A sites within the individual cell types that make up the brain has not been possible. Here, we develop a mouse model that enables transcriptome-wide m6A detection in any tissue of interest at single-cell resolution. We use these mice to map m6A across different brain regions and within single cells of the mouse cortex and discover a high degree of shared methylation across brain regions and cell types. However, we also identify a small number of differentially methylated mRNAs in neurons that encode important regulators of neuronal signaling, and we discover that microglia have lower levels of m6A than other cell types. Finally, we perform single-cell m6A mapping in aged mice and identify many transcripts with age-dependent changes in m6A.
- Open Access
- 22 April 2024
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 17, 1393973
Studying m6A in the brain: a perspective on current methods, challenges, and future directions
A major mechanism of post-transcriptional RNA regulation in cells is the addition of chemical modifications to RNA nucleosides, which contributes to nearly every aspect of the RNA life cycle. N6-methyladenosine (m6A) is a highly prevalent modification in cellular mRNAs and non-coding RNAs, and it plays important roles in the control of gene expression and cellular function. Within the brain, proper regulation of m6A is critical for neurodevelopment, learning and memory, and the response to injury, and m6A dysregulation has been implicated in a variety of neurological disorders. Thus, understanding m6A and how it is regulated in the brain is important for uncovering its roles in brain function and potentially identifying novel therapeutic pathways for human disease. Much of our knowledge of m6A has been driven by technical advances in the ability to map and quantify m6A sites. Here, we review current technologies for characterizing m6A and highlight emerging methods. We discuss the advantages and limitations of current tools as well as major challenges going forward, and we provide our perspective on how continued developments in this area can propel our understanding of m6A in the brain and its role in brain disease.
- 22 April 2024
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 17, 1393973
Open AccessStudying m6A in the brain: a perspective on current methods, challenges, and future directions
A major mechanism of post-transcriptional RNA regulation in cells is the addition of chemical modifications to RNA nucleosides, which contributes to nearly every aspect of the RNA life cycle. N6-methyladenosine (m6A) is a highly prevalent modification in cellular mRNAs and non-coding RNAs, and it plays important roles in the control of gene expression and cellular function. Within the brain, proper regulation of m6A is critical for neurodevelopment, learning and memory, and the response to injury, and m6A dysregulation has been implicated in a variety of neurological disorders. Thus, understanding m6A and how it is regulated in the brain is important for uncovering its roles in brain function and potentially identifying novel therapeutic pathways for human disease. Much of our knowledge of m6A has been driven by technical advances in the ability to map and quantify m6A sites. Here, we review current technologies for characterizing m6A and highlight emerging methods. We discuss the advantages and limitations of current tools as well as major challenges going forward, and we provide our perspective on how continued developments in this area can propel our understanding of m6A in the brain and its role in brain disease.
- Open Access
- 26 March 2024
- Published by Cold Spring Harbor Laboratory in RNA
- Vol. 30 (5) , 465-467
mRNA epitranscriptomics
Epitranscriptomics refers to chemical changes in RNAs and includes numerous chemical types with varying stoichiometry and functions. RNA modifications are highly diverse in chemistry and respond in cell-type- and cell-state-dependent manners that enable and facilitate the execution of a wide array of biological functions. This includes roles in the regulation of transcription, translation, chromatin maintenance, immune response, and many other processes. This special issue presents the past, present, and future of epitranscriptomics research with a focus on mRNA. It includes perspectives from experts in the field, with the goal of encouraging discussions and debates that will further advance this area of research and enable it to realize its full potential in basic research and applications to human health and disease.
- 26 March 2024
- Published by Cold Spring Harbor Laboratory in RNA
- Vol. 30 (5) , 465-467
Open AccessmRNA epitranscriptomics
Epitranscriptomics refers to chemical changes in RNAs and includes numerous chemical types with varying stoichiometry and functions. RNA modifications are highly diverse in chemistry and respond in cell-type- and cell-state-dependent manners that enable and facilitate the execution of a wide array of biological functions. This includes roles in the regulation of transcription, translation, chromatin maintenance, immune response, and many other processes. This special issue presents the past, present, and future of epitranscriptomics research with a focus on mRNA. It includes perspectives from experts in the field, with the goal of encouraging discussions and debates that will further advance this area of research and enable it to realize its full potential in basic research and applications to human health and disease.
- 20 March 2024
- Published by Springer Nature
- Vol. 2784, 147-161
Simultaneous In Situ Detection of m6A-Modified and Unmodified RNAs Using DART-FISH
N6-methyladenosine (m6A) is an abundant mRNA modification which plays important roles in regulating RNA function and gene expression. Traditional methods for visualizing mRNAs within cells cannot distinguish m6A-modified and unmodified versions of the target transcript, thus limiting our understanding of how and where methylated transcripts are localized within cells. Here, we describe DART-FISH, a visualization technique which enables simultaneous detection of both m6A-modified and unmodified target transcripts. DART-FISH combines m6A-dependent C-to-U editing with mutation-selective fluorescence in situ hybridization to specifically detect methylated and unmethylated transcript copies, enabling the investigation of m6A stoichiometry and methylated mRNA localization in single cells. Key words N6-methyladenosine (m6A) Fluorescent in situ hybridization (FISH) Padlock probe Epitranscriptomics RNA modifications Deamination adjacent to RNA modification targets (DART)
- 20 March 2024
- Published by Springer Nature
- Vol. 2784, 147-161
Simultaneous In Situ Detection of m6A-Modified and Unmodified RNAs Using DART-FISH
N6-methyladenosine (m6A) is an abundant mRNA modification which plays important roles in regulating RNA function and gene expression. Traditional methods for visualizing mRNAs within cells cannot distinguish m6A-modified and unmodified versions of the target transcript, thus limiting our understanding of how and where methylated transcripts are localized within cells. Here, we describe DART-FISH, a visualization technique which enables simultaneous detection of both m6A-modified and unmodified target transcripts. DART-FISH combines m6A-dependent C-to-U editing with mutation-selective fluorescence in situ hybridization to specifically detect methylated and unmethylated transcript copies, enabling the investigation of m6A stoichiometry and methylated mRNA localization in single cells. Key words N6-methyladenosine (m6A) Fluorescent in situ hybridization (FISH) Padlock probe Epitranscriptomics RNA modifications Deamination adjacent to RNA modification targets (DART)
- 2 January 2024
- Published by Springer Nature in Nature Biotechnology
- Vol. 42 (9) , 1417-1428
Programmable protein expression using a genetically encoded m6A sensor
The N6-methyladenosine (m6A) modification is found in thousands of cellular mRNAs and is a critical regulator of gene expression and cellular physiology. m6A dysregulation contributes to several human diseases, and the m6A methyltransferase machinery has emerged as a promising therapeutic target. However, current methods for studying m6A require RNA isolation and do not provide a real-time readout of mRNA methylation in living cells. Here we present a genetically encoded m6A sensor (GEMS) technology, which couples a fluorescent signal with cellular mRNA methylation. GEMS detects changes in m6A caused by pharmacological inhibition of the m6A methyltransferase, giving it potential utility for drug discovery efforts. Additionally, GEMS can be programmed to achieve m6A-dependent delivery of custom protein payloads in cells. Thus, GEMS is a versatile platform for m6A sensing that provides both a simple readout for m6A methylation and a system for m6A-coupled protein expression.
- 2 January 2024
- Published by Springer Nature in Nature Biotechnology
- Vol. 42 (9) , 1417-1428
Programmable protein expression using a genetically encoded m6A sensor
The N6-methyladenosine (m6A) modification is found in thousands of cellular mRNAs and is a critical regulator of gene expression and cellular physiology. m6A dysregulation contributes to several human diseases, and the m6A methyltransferase machinery has emerged as a promising therapeutic target. However, current methods for studying m6A require RNA isolation and do not provide a real-time readout of mRNA methylation in living cells. Here we present a genetically encoded m6A sensor (GEMS) technology, which couples a fluorescent signal with cellular mRNA methylation. GEMS detects changes in m6A caused by pharmacological inhibition of the m6A methyltransferase, giving it potential utility for drug discovery efforts. Additionally, GEMS can be programmed to achieve m6A-dependent delivery of custom protein payloads in cells. Thus, GEMS is a versatile platform for m6A sensing that provides both a simple readout for m6A methylation and a system for m6A-coupled protein expression.
- Open Access
- 9 October 2023
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 51 (20) , e101
In situ visualization of m6A sites in cellular mRNAs
N6-methyladenosine (m6A) is an abundant RNA modification which plays critical roles in RNA function and cellular physiology. However, our understanding of how m6A is spatially regulated remains limited due to a lack of methods for visualizing methylated transcripts of interest in cells. Here, we develop DART-FISH, a method for in situ visualization of specific m6A sites in target RNAs which enables simultaneous detection of both m6A-modified and unmodified transcript copies. We demonstrate the ability of DART-FISH to visualize m6A in a variety of mRNAs across diverse cell types and to provide information on the location and stoichiometry of m6A sites at single-cell resolution. Finally, we use DART-FISH to reveal that m6A is not sufficient for mRNA localization to stress granules during oxidative stress. This technique provides a powerful tool for examining m6A-modified transcript dynamics and investigating methylated RNA localization in individual cells.
- 9 October 2023
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 51 (20) , e101
Open AccessIn situ visualization of m6A sites in cellular mRNAs
N6-methyladenosine (m6A) is an abundant RNA modification which plays critical roles in RNA function and cellular physiology. However, our understanding of how m6A is spatially regulated remains limited due to a lack of methods for visualizing methylated transcripts of interest in cells. Here, we develop DART-FISH, a method for in situ visualization of specific m6A sites in target RNAs which enables simultaneous detection of both m6A-modified and unmodified transcript copies. We demonstrate the ability of DART-FISH to visualize m6A in a variety of mRNAs across diverse cell types and to provide information on the location and stoichiometry of m6A sites at single-cell resolution. Finally, we use DART-FISH to reveal that m6A is not sufficient for mRNA localization to stress granules during oxidative stress. This technique provides a powerful tool for examining m6A-modified transcript dynamics and investigating methylated RNA localization in individual cells.
- Top Cited PapersOpen Access
- 20 June 2023
- Published by Annual Reviews in Annual Review of Biochemistry
- Vol. 92 (1) , 145-173
The Proteins of mRNA Modification: Writers, Readers, and Erasers
Over the past decade, mRNA modifications have emerged as important regulators of gene expression control in cells. Fueled in large part by the development of tools for detecting RNA modifications transcriptome wide, researchers have uncovered a diverse epitranscriptome that serves as an additional layer of gene regulation beyond simple RNA sequence. Here, we review the proteins that write, read, and erase these marks, with a particular focus on the most abundant internal modification, N6-methyladenosine (m6A). We first describe the discovery of the key enzymes that deposit and remove m6A and other modifications and discuss how our understanding of these proteins has shaped our views of modification dynamics. We then review current models for the function of m6A reader proteins and how our knowledge of these proteins has evolved. Finally, we highlight important future directions for the field and discuss key questions that remain unanswered.
- 20 June 2023
- Published by Annual Reviews in Annual Review of Biochemistry
- Vol. 92 (1) , 145-173
Top Cited PapersOpen AccessThe Proteins of mRNA Modification: Writers, Readers, and Erasers
Over the past decade, mRNA modifications have emerged as important regulators of gene expression control in cells. Fueled in large part by the development of tools for detecting RNA modifications transcriptome wide, researchers have uncovered a diverse epitranscriptome that serves as an additional layer of gene regulation beyond simple RNA sequence. Here, we review the proteins that write, read, and erase these marks, with a particular focus on the most abundant internal modification, N6-methyladenosine (m6A). We first describe the discovery of the key enzymes that deposit and remove m6A and other modifications and discuss how our understanding of these proteins has shaped our views of modification dynamics. We then review current models for the function of m6A reader proteins and how our knowledge of these proteins has evolved. Finally, we highlight important future directions for the field and discuss key questions that remain unanswered.